$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Affinity Apheresis for Treatment of Bacteremia Caused by Staphylococcus aureus and/or Methicillin-Resistant S. aureus (MRSA) 원문보기

Journal of microbiology and biotechnology, v.21 no.6, 2011년, pp.659 - 664  

Mattsby-Baltzer, Inger (Department of Infectious Diseases) ,  Bergstrom, Tomas (Department of Infectious Diseases) ,  Mccrea, Keith (Emergence LLC) ,  Ward, Robert (Emergence LLC) ,  Msc, Lars Adolfsson (ExThera AB, Karolinska Science Park) ,  Larm, Olle (ExThera AB, Karolinska Science Park)

Abstract AI-Helper 아이콘AI-Helper

Staphylococcus aureus (SA) bacteremia is associated with high mortality, and often results in metastatic infections. The methicillin-resistant SA (MRSA) is an urgent health care issue, as nosocomial infections with these bacteria represent limited treatment alternatives. Samples of whole blood conta...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

가설 설정

  • We hypothesize that when infected blood is passed through a device, consisting of a column packed with beads coated with biologically active heparin (i.e., end-point attached), many bacteria including SA would be removed. Our aim was to investigate to what extent SA and MRSA are removed from whole blood after passage over surface-heparinized polyethylene beads.
본문요약 정보가 도움이 되었나요?

참고문헌 (37)

  1. Axelsson, J., M. Ferreira, L. Adolfsson, K. McCrea, R. Ward, and O. Larm. 2010. Cytokines in blood from septic patients interact with surface-immobilized heparin. ASAIO J. 56: 48-51. 

  2. Brakstad, O. G., K. Aasbakk, and J. A. Maeland. 1992. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J. Clin. Microbiol. 30: 1654-1660. 

  3. Brandtzaeg, P., A. Bjerre, R. Ovstebo, B. Brusletto, G. B. Joo, and P. Kierulf. 2001. Neisseria meningitidis lipopolysaccharides in human pathology. J. Endotoxin Res. 7: 401-420. 

  4. Cai, B., E. A. Deitch, and L. Ulloa. 2010. Novel insights for systemic inflammation in sepsis and hemorrhage. Mediators Inflamm. 2010: 642462. 

  5. Carleton, H. A., B. A. Diep, E. D. Charlebois, G. F. Sensabaugh, and F. Perdreau-Remington. 2004. Community-adapted methicillinresistant Staphylococcus aureus (MRSA): Population dynamics of an expanding community reservoir of MRSA. J. Infect. Dis. 190: 1730-1738. 

  6. Cosgrove, S. E., G. Sakoulas, E. N. Perencevich, M. J. Schwaber, A. W. Karchmer, and Y. Carmeli. 2003. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin. Infect. Dis. 36: 53-59. 

  7. David, M. Z. and R. S. Daum. 2010. Community-associated methicillin-resistant Staphylococcus aureus: Epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev. 23: 616-687. 

  8. Hackett, S. J., M. Guiver, J. Marsh, J. A. Sills, A. P. Thomson, E. B. Kaczmarski, and C. A. Hart. 2002. Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch. Dis. Child. 86: 44-46. 

  9. Hess, D. J., M. J. Henry-Stanley, S. L. Erlandsen, and C. L. Wells. 2006. Heparan sulfate proteoglycans mediate Staphylococcus aureus interactions with intestinal epithelium. Med. Microbiol. Immunol. 195: 133-141. 

  10. Hsu, R. B. 2005. Risk factors for nosocomial infective endocarditis in patients with methicillin-resistant Staphylococcus aureus bacteremia. Infect. Control Hosp. Epidemiol. 26: 654-657. 

  11. Jessen, M. E. 2006. Pro: Heparin-coated circuits should be used for cardiopulmonary bypass. Anesth. Analg. 103: 1365-1369. 

  12. Kollef, M. H. 2000. Inadequate antimicrobial treatment: An important determinant of outcome for hospitalized patients. Clin. Infect. Dis. 31 (Suppl 4): S131-S138. 

  13. Lala, H. M., G. D. Mills, K. Barratt, J. Bonning, N. E. Manikkam, and D. Martin. 2007. Meningococcal disease deaths and the frequency of antibiotic administration delays. J. Infect. 54: 551-557. 

  14. Larm, O., R. Larsson, and P. Olsson. 1983. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater. Med. Devices Artif. Organs 11: 161-173. 

  15. Liang, O. D., F. Ascencio, L. A. Fransson, and T. Wadstrom. 1992. Binding of heparan sulfate to Staphylococcus aureus. Infect. Immun. 60: 899-906. 

  16. Liang, O. D., F. Ascencio, R. Vazquezjuarez, and T. Wadstrom. 1993. Binding of collagen, fibronectin, lactoferrin, laminin, vitronectin and heparan-sulfate to Staphylococcus aureus strain- V8 at various growth phases and under nutrient stress conditions. Zentralbl. Bakteriol. Microbiol. Hyg. A 279: 180-190. 

  17. Lisboa, T., G. Waterer, and J. Rello. 2010. We should be measuring genomic bacterial load and virulence factors. Crit. Care Med. 38: S656-S662. 

  18. Ljungh, A. and T. Wadstrom. 1995. Growth-conditions influence expression of cell-surface hydrophobicity of staphylococci and other wound-infection pathogens. Microbiol. Immunol. 39: 753- 757. 

  19. Lowy, F. D. 1998. Staphylococcus aureus infections. N Engl. J. Med. 339: 520-532. 

  20. Olofsson, S. and T. Bergstrom. 2005. Glycoconjugate glycans as viral receptors. Ann. Med. 37: 154-172. 

  21. Ovstebo, R., P. Brandtzaeg, B. Brusletto, K. B. Haug, K. Lande, E. A. Hoiby, and P. Kierulf. 2004. Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J. Clin. Microbiol. 42: 2980-2987. 

  22. Payen, D., J. Mateo, J. M. Cavaillon, F. Fraisse, C. Floriot, and E. Vicaut. 2009. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: A randomized controlled trial. Crit. Care Med. 37: 803-810. 

  23. Pertosa, G., G. Grandaliano, L. Gesualdo, and F. P. Schena. 2000. Clinical relevance of cytokine production in hemodialysis. Kidney Int. 76: S104-S111. 

  24. Peters, R. P., M. A. van Agtmael, S. Gierveld, S. A. Danner, A. B. Groeneveld, C. M. Vandenbroucke-Grauls, and P. H. Savelkoul. 2007. Quantitative detection of Staphylococcus aureus and Enterococcus faecalis DNA in blood to diagnose bacteremia in patients in the intensive care unit. J. Clin. Microbiol. 45: 3641- 3646. 

  25. Rello, J., T. Lisboa, M. Lujan, M. Gallego, C. Kee, I. Kay, D. Lopez, and G. W. Waterer. 2009. Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 136: 832-840. 

  26. Riesenfeld, J. and L. Roden. 1990. Quantitative analysis of Nsulfated, N-acetylated, and unsubstituted glucosamine amino groups in heparin and related polysaccharides. Anal. Biochem. 188: 383-389. 

  27. Ronco, C., R. Bellomo, P. Homel, A. Brendolan, M. Dan, P. Piccinni, and G. La Greca. 2000. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 356: 26-30. 

  28. Schefold, J. C., S. von Haehling, M. Corsepius, C. Pohle, P. Kruschke, H. Zuckermann, H. D. Volk, and P. Reinke. 2007. A novel selective extracorporeal intervention in sepsis: Immunoadsorption of endotoxin, interleukin 6, and complementactivating product 5a. Shock 28: 418-425. 

  29. Segreti, J. 2005. Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistance. Clin. Microbiol. Infect. 11 (Suppl 3): 29-35. 

  30. Tang, L. and J. W. Eaton. 1995. Inflammatory responses to biomaterials. Am. J. Clin. Pathol. 103: 466-471. 

  31. Tetta, C., V. D'Intini, R. Bellomo, M. Bonello, V. Bordoni, Z. Ricci, and C. Ronco. 2003. Extracorporeal treatments in sepsis: Are there new perspectives? Clin. Nephrol. 60: 299-304. 

  32. Wadstrom, T. and A. Ljungh. 1999. Glycosaminoglycan-binding microbial proteins in tissue adhesion and invasion: Key events in microbial pathogenicity. J. Med. Microbiol. 48: 223-233. 

  33. Valente, A. M., R. Jain, M. Scheurer, V. G. Fowler Jr., G. R. Corey, A. R. Bengur, S. Sanders, and J. S. Li. 2005. Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia. Pediatrics 115: e15-e19. 

  34. van der Poll, T. and S. M. Opal. 2008. Host-pathogen interactions in sepsis. Lancet Infect. Dis. 8: 32-43. 

  35. van Haeften, R., S. Palladino, I. Kay, T. Keil, C. Heath, and G. W. Waterer. 2003. A quantitative LightCycler PCR to detect Streptococcus pneumoniae in blood and CSF. Diagn. Microbiol. Infect. Dis. 47: 407-414. 

  36. Venkataraman, R., S. Subramanian, and J. A. Kellum. 2003. Clinical review: Extracorporeal blood purification in severe sepsis. Crit. Care 7: 139-145. 

  37. Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39: 309-317. 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로